Back

Effects of SGLT2 inhibitors in diabetic patients receiving doxorubicin-based chemotherapy for breast cancer

21 May 2022 (08:30 - 18:50)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 2 Clinical HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Mahmoud Abdelnabi

Mayo Clinic Hospital, Phoenix (United States of America)

34 More presentations in this session

Presentation thumbnail
Abnormal central hemodynamics and heart rate in heart failure with preserved ejection fraction
Professor H. Tomiyama (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Geriatric assessment in not selected patients admitted for acute heart failure
Miss L. Aguilar Iglesias (Burgos, ES)
Abstract Slides
Presentation thumbnail
Goldberger Triad revisited- is RS<1 V4 a simple marker for dilated left ventricle?
Doctor I. Chung (Singapore, SG)
Abstract Slides
Presentation thumbnail
Heart failure risk score: predictive value of C2HEST score for one-year mortality and re-admission after discharge
Doctor J. Correia (Viseu, PT)
Abstract Slides
Presentation thumbnail
An adverse hemodynamic profile does not explain increased mortality in heart failure patients with diabetes: An invasive cohort study
Miss B. Heegaard (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 2

The Event

Event poster

Heart Failure 2022

21 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources